Literature DB >> 15145628

Statins for the treatment of multiple sclerosis: cautious hope.

Chris H Polman1, Joep Killestein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15145628     DOI： 10.1016/S0140-6736(04)16237-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  [Statins for treatment of CNS diseases. Status report from research and clinical practice].

Authors:  T Menge; H-C von Büdingen; S S Zamvil; H-P Hartung; B C Kieseier; O Stüve
Journal:  Nervenarzt       Date:  2005-04       Impact factor: 1.214

2.  Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials.

Authors:  Liam Smeeth; Ian Douglas; Andrew J Hall; Richard Hubbard; Stephen Evans
Journal:  Br J Clin Pharmacol       Date:  2008-11-05       Impact factor: 4.335

3.  Atorvastatin reduces IOP in ocular hypertension in vivo and suppresses ECM in trabecular meshwork perhaps via FGD4.

Authors:  Xiang-Yuan Song; Ya-Ying Chen; Wen-Ting Liu; Lin Cong; Jin-Ling Zhang; Yang Zhang; Yu-Yan Zhang
Journal:  Int J Mol Med       Date:  2022-04-13       Impact factor: 5.314
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.